Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer

Go back to Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
AGIOS PHARM (NASDAQ: AGIO) Delayed: 34.16 +1.08 (3.26%)
Previous Close $33.08    52 Week High $71.49 
Open $33.90    52 Week Low $33.50 
Day High $34.45    P/E N/A 
Day Low $33.50    EPS $-1.18 
Volume 2,241,589       

(NASDAQ: MCRB) Delayed: 6.61 +0.15 (2.32%)
Previous Close $6.46    52 Week High $44.51 
Open $6.40    52 Week Low $8.05 
Day High $6.70    P/E N/A 
Day Low $6.08    EPS $0.00 
Volume 124,619       

(NASDAQ: TTOO) Delayed: 0.13 --0 (-0%)
Previous Close $0.13    52 Week High $12.00 
Open $0.13    52 Week Low $4.92 
Day High $0.13    P/E N/A 
Day Low $0.13    EPS $0.00 
Volume 1,647       

ACCELERON PHARMA (NASDAQ: XLRN) Delayed: 178.75 --0 (-0%)
Previous Close $178.75    52 Week High $50.86 
Open $178.75    52 Week Low $22.67 
Day High $178.75    P/E 16.93 
Day Low $178.75    EPS $10.56 
Volume 158,297